In the Media
Are you looking for the latest media coverage of the BioMed X Institute, its research projects and people behind the innovation model? Here you will find the latest clippings – hot off the press!
BioMed X Launches a New Call for Application in Autoimmune Disease Research
Yahoo! Finance
BioMed X, a biomedical research institute, announced the launch of a Call for Application in immunology. This call aims to assemble a new research team to develop innovative strategies for neutralizing autoreactive plasma cells in the context of autoimmune disease.
BioMed X Launches a New Call for Application in Autoimmune Disease Research
MarketWatch
BioMed X, an independent biomedical research institute, announced yesterday the launch of a Call for Application in immunology. This call aims to assemble a new research team to develop innovative strategies for neutralizing autoreactive plasma cells in the context of autoimmune disease.
BioMed X and AbbVie Start New Research Project in the USA
Yahoo! Finance
BioMed X, an independent biomedical research institute, announces the start of a research project in collaboration with AbbVie to be hosted by the new BioMed X Institute in New Haven, CT, USA. The project aims to generate an organotypic human arterial model with sufficient complexity to recapitulate key characteristics of chronic autoimmune disease onset, progression, and resolution, with the long-term…
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development
Yahoo! Finance
BioMed X, a German independent research institute, announces the start of its first research project in collaboration with Sanofi: “Next Generation Virtual Patient Engine for Clinical Translation of Drug Candidates” (VPE). The end goal of this research project is to develop a versatile computational platform that can predict the efficacy of first- or best-in-class drug candidates in virtual patient populations…
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development
Newswire
The “Next Generation Virtual Patient Engine for Clinical Translation of Drug Candidates” (VPE) team joins eight other active research teams at the BioMed X Institute in Germany, and it is one of four new projects launched by BioMed X in 2023. To learn more about this new AI-based research group, visit the BioMed X Institute website at www.bio.mx.
Das BioMed X Institute startet sein erstes Forschungsprojekt mit Sanofi zur Anwendung von kĂĽnstlicher Intelligenz in der Arzneimittelentwicklung
Wallstreet Online
Ein neues BioMed X-Forschungsteam wird mit UnterstĂĽtzung von Sanofi eine Computerplattform entwickeln, die die Entwicklung von Medikamenten beschleunigen soll.
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development
Bloomberg
BioMed X, a German independent research institute, announces the start of its first research project in collaboration with Sanofi: “Next Generation Virtual Patient Engine for Clinical Translation of Drug Candidates” (VPE).
Inspiring, Exciting, Unforgettable: Fueling Innovation in Science
Chemistry Views
Even in case of a large chemical or pharmaceutical company, 99.99 % of all scientists work outside of the organization. So, as a company, how can you increase the percentage of scientists involved in generating new ideas? And how do you attract the best minds to participate?
Johnson & Johnson sucht Innovationen in DĂĽsseldorf, Heidelberg und MĂĽnchen
Transkript
Das Innovationsteam von Johnson & Johnson in Europa hat in der vergangenen Woche den drei “fĂĽhrenden Ă–kosystemen der Biowissenschaften in Deutschland” (so die Eigendarstellung des Unternehmens) einen Besuch abgestattet. Man wollte sich persönlich in DĂĽsseldorf, Heidelberg und MĂĽnchen mit Unternehmern, Akademikern, TechnologietransferbĂĽros und anderen fĂĽhrenden Köpfen der Biowissenschaften treffen.